24 HR mesalamine 375 MG Extended Release Oral Capsule

RxCUI: 825130
RxNorm name: 24 HR mesalamine 375 MG Extended Release Oral Capsule
Display name: 24 HR mesalamine 375 MG Extended Release Oral Capsule
Full name: 24 HR mesalamine 375 MG Extended Release Oral Capsule
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mesalamine	MESALAMINE	Golden State Medical Supply, Inc.	4c4ffb68-3ca4-35cd-e063-6294a90ab929	2026-03-05	Warnings, Adverse reactions	Exact identifier rxcui: 825130
MESALAMINE	MESALAMINE	Camber Pharmaceuticals, Inc.	ef471372-8d9f-4d95-9371-44522c69058f	2025-12-10	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Ingenus Pharmaceuticals, LLC	58503afe-b8d4-4710-a194-e3acd64ecf1f	2025-12-05	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Upsher-Smith Laboratories, LLC	1e6978d0-01db-477d-a90f-27561777480f	2025-12-01	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	American Health Packaging	e638681d-8fca-4bf8-a1fb-8e52357a64da	2025-05-21	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	AvPAK	f2657911-6f06-71fb-e053-2a95a90ae6f7	2025-01-09	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Zydus Lifesciences Limited	04073681-a834-4f45-91c5-224b608b30e6	2024-11-30		Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Ascend Laboratories, LLC	43f69db3-81ac-4da4-a61f-fbba6299d9c2	2024-07-03	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Aurobindo Pharma Limited	d6c0fc76-644e-4301-9672-f432061e3d37	2024-01-20	Warnings, Adverse reactions	Exact identifier rxcui: 825130
APRISO	MESALAMINE	Salix Pharmaceuticals, Inc.	7951139c-b271-45a4-b523-34b23800917b	2024-01-09	Warnings, Adverse reactions	Exact identifier rxcui: 825130
MESALAMINE	MESALAMINE	Alembic Pharmaceuticals Inc.	87d3d62d-2dc3-4e6f-be33-cabbca12e8f7	2024-01-09	Warnings, Adverse reactions	Exact identifier rxcui: 825130
mesalamine	MESALAMINE	Teva Pharmaceuticals USA, Inc.	8d27a608-3ba1-4799-be38-c00fb08ce3ce	2023-12-19	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Mylan Pharmaceuticals Inc.	c8b93ea3-0367-4605-b87f-06c3812ff3b7	2023-11-30	Warnings, Adverse reactions	Exact identifier rxcui: 825130
mesalamine	MESALAMINE	Oceanside Pharmaceuticals	cfe4800f-868f-46fd-8b9a-977a91ae5fbe	2023-10-31	Warnings, Adverse reactions	Exact identifier rxcui: 825130
Mesalamine	MESALAMINE	Zydus Pharmaceuticals USA Inc.	cd8493f7-91fd-4c2d-b3d7-c1301825586b	2023-10-26	Warnings, Adverse reactions	Exact identifier rxcui: 825130
MESALAMINE	MESALAMINE	Alembic Pharmaceuticals Limited	4ef59b85-e5a5-479f-a1fe-e1cee4d87670	2022-11-07	Warnings, Adverse reactions	Exact identifier rxcui: 825130

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 17 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7951139c-b271-45a4-b523-34b23800917b	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	34	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20240109
43f69db3-81ac-4da4-a61f-fbba6299d9c2	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	14	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987	20240703
cfe4800f-868f-46fd-8b9a-977a91ae5fbe	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	9	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987	20231031
8d27a608-3ba1-4799-be38-c00fb08ce3ce	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	8	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987	20231219
87d3d62d-2dc3-4e6f-be33-cabbca12e8f7	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	7	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20240109
d6c0fc76-644e-4301-9672-f432061e3d37	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	5	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20240120
c8b93ea3-0367-4605-b87f-06c3812ff3b7	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	5	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20231130
1e6978d0-01db-477d-a90f-27561777480f	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	4	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20251201
e638681d-8fca-4bf8-a1fb-8e52357a64da	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	4	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987	20250521
cd8493f7-91fd-4c2d-b3d7-c1301825586b	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	4	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20231026
04073681-a834-4f45-91c5-224b608b30e6	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	3	MESALAMINE Extended-Release Capsules	20241130
ef471372-8d9f-4d95-9371-44522c69058f	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	2	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20251210
58503afe-b8d4-4710-a194-e3acd64ecf1f	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	2	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES s afely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20251205
f2657911-6f06-71fb-e053-2a95a90ae6f7	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	2	Mesalamine Extended Release Rx Only These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. Initial U.S. Approval: 1987	20250109
d5d05b1f-9f45-4f66-9f75-3c67934105de	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	2	These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987	20120215
4c4ffb68-3ca4-35cd-e063-6294a90ab929	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	1	MESALAMINE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20260305
4ef59b85-e5a5-479f-a1fe-e1cee4d87670	mesalamine 0.375 GM 24HR Extended Release Oral Capsule [PSN] · 24 HR mesalamine 375 MG Extended Release Oral Capsule [SCD] · mesalamine 375 MG 24 HR Extended Release Oral Capsule [SY] · mesalazine 375 MG 24 HR Extended Release Oral Capsule [SY]	4	1	These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987	20221107